Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$879M |
| 2 |
Nutrien
NTR
|
+$561M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$465M |
| 4 |
Netflix
NFLX
|
+$312M |
| 5 |
Amazon
AMZN
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$622M |
| 2 |
POT
Potash Corp Of Saskatchewan
POT
|
+$434M |
| 3 |
Blackstone
BX
|
+$392M |
| 4 |
AGU
Agrium
AGU
|
+$329M |
| 5 |
AABA
Altaba Inc
AABA
|
+$256M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.84% |
| 2 | Technology | 10.38% |
| 3 | Miscellaneous | 9.99% |
| 4 | Energy | 9.18% |
| 5 | Communication Services | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2676
KRONOS Worldwide
KRO
$878M
| $182K | ﹤0.01% |
8,037
-3,061
| -28% | -$76.2K |
2015 Q4
9 quarters
|
|
2677
Northeast Bank
NBN
$1.07B
| $181K | ﹤0.01% |
8,837
+1,270
| +17% | +$28.6K |
2016 Q4
5 quarters
|
|
2678
State Street SPDR S&P Pharmaceuticals ETF
XPH
$526M
| $181K | ﹤0.01% |
4,326
| – | – |
2016 Q3
6 quarters
|
|
|
HTGM
2679
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $181K | ﹤0.01% |
+278
| New | +$209K |
2018 Q1
0 quarters
|
|
2680
Rapid7
RPD
$813M
| $180K | ﹤0.01% |
7,002
-79,839
| -92% | -$1.93M |
2017 Q2
3 quarters
|
|
2681
Atara Biotherapeutics
ATRA
$84.9M
| $179K | ﹤0.01% |
184
| – | – |
2017 Q2
3 quarters
|
|
2682
Amplify Blockchain Technology ETF
BLOK
$1.06B
| $178K | ﹤0.01% |
+9,300
| New | +$185K |
2018 Q1
0 quarters
|
|
2683
Ocular Therapeutix
OCUL
$1.6B
| $178K | ﹤0.01% |
27,375
+1,919
| +8% | +$10.8K |
2016 Q3
6 quarters
|
|
|
EXAS
2684
DELISTED
Exact Sciences
EXAS
| $177K | ﹤0.01% |
4,386
-26,868
| -86% | -$1.31M |
2013 Q2
19 quarters
|
|
|
MSF
2685
DELISTED
Morgan Stanley Emerging Mkts Fd
MSF
| $177K | ﹤0.01% |
9,617
-537
| -5% | -$10.1K |
2017 Q2
3 quarters
|
|
2686
AMN Healthcare
AMN
$1.39B
| $175K | ﹤0.01% |
3,088
| – | – |
2013 Q2
19 quarters
|
|
2687
First Internet Bancorp
INBK
$237M
| $175K | ﹤0.01% |
4,742
| – | – |
2017 Q1
4 quarters
|
|
2688
Lloyds Banking Group
LYG
$77.9B
| $175K | ﹤0.01% |
46,906
-348
| -0.7% | -$1.35K |
2013 Q2
19 quarters
|
|
2689
Insulet
PODD
$9.07B
| $175K | ﹤0.01% |
2,017
| – | – |
2013 Q2
19 quarters
|
|
2690
Schwab US Large-Cap Growth ETF
SCHG
$63.8B
| $175K | ﹤0.01% |
19,544
+7,400
| +61% | +$68.2K |
2014 Q2
15 quarters
|
|
|
ELLI
2691
DELISTED
Ellie Mae Inc
ELLI
| $175K | ﹤0.01% |
1,903
-200
| -10% | -$18.6K |
2013 Q2
19 quarters
|
|
|
ESL
2692
DELISTED
Esterline Technologies
ESL
| $175K | ﹤0.01% |
2,396
+294
| +14% | +$21.9K |
2013 Q2
19 quarters
|
|
2693
American Homes 4 Rent
AMH
$11B
| $174K | ﹤0.01% |
8,611
-25,023
| -74% | -$498K |
2014 Q2
15 quarters
|
|
2694
Noodles & Co
NDLS
$82.3M
| $174K | ﹤0.01% |
2,888
-3,225
| -53% | -$164K |
2017 Q1
4 quarters
|
|
|
PFN
2695
PIMCO Income Strategy Fund II
PFN
$617M
| $173K | ﹤0.01% |
16,600
+6,600
| +66% | +$68.2K |
2015 Q1
12 quarters
|
|
2696
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$555M
| $172K | ﹤0.01% |
108
+60
| +125% | +$112K |
2017 Q4
1 quarter
|
|
2697
Vanguard Energy ETF
VDE
$10.6B
| $172K | ﹤0.01% |
1,866
| – | – |
2017 Q4
1 quarter
|
|
|
ABTX
2698
DELISTED
Allegiance Bancshares
ABTX
| $172K | ﹤0.01% |
4,382
| – | – |
2017 Q1
4 quarters
|
|
|
CRC
2699
CALL
DELISTED
California Resources Corporation
CRC
| $172K | ﹤0.01% |
10,000
-62,500
| -86% | -$1.17M |
2017 Q4
1 quarter
|
|
|
LPNT
2700
DELISTED
LifePoint Health, Inc.
LPNT
| $171K | ﹤0.01% |
3,645
+1,704
| +88% | +$82K |
2013 Q2
19 quarters
|
|
Similar funds
Bank of Montreal's Q1 2018 Portfolio in Review
As of Q1 2018, Bank of Montreal held 4,545 positions worth $112B, down 2.7% from $115B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Bank of Montreal's Q1 2018 filing shows 332 new, 1,572 increased, 1,567 reduced and 334 closed positions. Its largest new stake was Nutrien: 11,201,924 shares worth $529M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $622M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Technology and Miscellaneous.
- Bank of Montreal's largest Q1 2018 buy was Nutrien: 11,201,924 shares worth $529M.
- Bank of Montreal added most to iShares Core S&P 500 ETF in Q1 2018, an estimated $879M increase.
- Bank of Montreal's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $622M.
- Bank of Montreal fully exited Potash Corp Of Saskatchewan in Q1 2018, selling an estimated $434M.
- Bank of Montreal's ten largest holdings make up 20% of its $112B portfolio in Q1 2018.
- Bank of Montreal opened 332 new positions and closed 334 in Q1 2018.
- Bank of Montreal's portfolio value fell 2.7% quarter-over-quarter to $112B.
Based on Bank of Montreal's 13F filing for Q1 2018, filed 13 Apr 2018.